Need professional-grade analysis? Visit stockanalysis.com
$8.37B
45.82
1,219
0.98%
Zhejiang Ausun Pharmaceutical Co Ltd (603229) trades on SHG in CNY. The company is classified in the Healthcare sector under the Biotechnology industry. The stock currently trades at CNY10.07, down 1.66% from the previous close.
Over the past year, 603229 has traded between a low of CNY7.77 and a high of CNY12.31. The stock has gained 25.9% over this period. It is currently 18.2% below its 52-week high.
Zhejiang Ausun Pharmaceutical Co Ltd has a market capitalization of $8.37B, with a price-to-earnings ratio of 45.82 and a dividend yield of 0.98%.
Zhejiang Ausun Pharmaceutical Co., Ltd. engages in the research and development, process development, manufacture, and sale of APIs and pharmaceutical intermediates. It offers fluorine products, prostaglandins, antimicrobials, and oncology products. The company also provides products for liver disease, respiratory system, and cardiac and cerebral vessels, as well as CNS indications. In addition, it offers development and manufacturing services to the pharmaceutical, cosmetics, and nutritional industries. The company was founded in 2010 and is based in Linhai, China.
Side-by-side comparison against top Healthcare peers.